The acute dialysis quality initiative - Part IV: Membranes for CRRT

  • Clark W
  • Leblanc M
  • Levin N
  • 5


    Mendeley users who have this article in their library.
  • 0


    Citations of this article.


The extracorporeal membrane used in a continuous renal replacement therapy (CRRT) for the treatment of a critically ill patient with acute renal failure (ARF) is vitally important for several reasons, including its influence on biocompatibility and filter performance. The clinical relevance of membrane-related biocompatibility markers traditionally used in chronic hemodialysis remains unclear in CRRT. Numerous approaches may be used to assess membrane and filter performance in CRRT, but no specific methodology is accepted widely at present. Although a potential benefit of certain membranes used for CRRT is adsorptive removal of inflammatory mediators, this issue has not been assessed carefully in well-designed clinical trials. These and other issues should be the subject of future clinical research efforts. © 2002 by the National Kidney Foundation, Inc.

Author-supplied keywords

  • Acute renal failure
  • Biocompatibility
  • Continuous renal replacement therapy
  • Filter
  • Membrane

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • William R. Clark

  • Martine Leblanc

  • Nathan W. Levin

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free